Evidence map›Paper›PMID 36807645›Full record

ArticleNature structural & molecular biology2023

Modeling HIV-1 nuclear entry with nucleoporin-gated DNA-origami channels.

Qi Shen, Qingzhou Feng, Chunxiang Wu, Qiancheng Xiong, Taoran Tian, Shuai Yuan, Jiong Shi, Gregory J Bedwell, Ran Yang, Christopher Aiken and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Viral interference of nucleocytoplasmic transport.The Journal of biological chemistry · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Qi ShenDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.ORCID 0000-0002-9062-8955
Qingzhou FengDepartment of Cell Biology, Yale School of Medicine, New Haven, CT, USA.
Chunxiang WuDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.ORCID 0000-0002-8635-1578
Qiancheng XiongDepartment of Cell Biology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-9897-7391
Taoran TianNanobiology Institute, Yale University, West Haven, CT, USA.
Shuai YuanDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
Jiong ShiDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Gregory J BedwellDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Ran YangDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.ORCID 0000-0002-3637-6865
Christopher AikenDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Alan N EngelmanDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0002-9709-2591
C Patrick LuskDepartment of Cell Biology, Yale School of Medicine, New Haven, CT, USA.
Chenxiang LinDepartment of Cell Biology, Yale School of Medicine, New Haven, CT, USA. chenxiang.lin@yale.edu.ORCID 0000-0001-7041-1946
Yong XiongDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA. yong.xiong@yale.edu.ORCID 0000-0001-9625-9313
Yale University · USHarvard University · USVanderbilt University Medical Center · US

Funding

Project 3. IntegrationU54AI170791 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Zandrea Ambrose · 2022 to 2026
$30.6M
Technology Development 2: MAS NMR and dynamic nuclear polarization for HIV-1 structural biologyP50AI150481 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GRONENBORN, ANGELA M. · 2019 to 2021
$14.1M
Nuclear Localization of HIV-1 Preintegration ComplexesR01AI052014 · NIAID · DANA-FARBER CANCER INSTITUTE · PI ENGELMAN, ALAN N. · 2003 to 2025
$11.4M
Postdoctoral Training Program in AIDS-related ResearchT32AI007386 · NIAID · DANA-FARBER CANCER INSTITUTE · PI CANTOR, HARVEY, ENGELMAN, ALAN N. · 1990 to 2023
$5.3M
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrierR01GM105672 · NIGMS · YALE UNIVERSITY · PI LUSK, CHARLES PATRICK · 2013 to 2025
$4.6M
A multiscale approach for elucidating nuclear entry mechanisms of HIV-1 capsidR01AI162260 · NIAID · YALE UNIVERSITY · PI LIN, CHENXIANG, XIONG, YONG · 2021 to 2025
$3.5M
Generating nuclear pore complex mimics with DNA origamiR21GM109466 · NIGMS · YALE UNIVERSITY · PI LIN, CHENXIANG, LUSK, CHARLES PATRICK · 2014 to 2015
$458k
NIAID NIH HHS P50 AI150481NIAID NIH HHS R01 AI052014NIAID NIH HHS R01 AI162260NIAID NIH HHS T32 AI007386NIAID NIH HHS U54 AI170791NIGMS NIH HHS R01 GM105672NIGMS NIH HHS R21 GM109466
6 · The paper itself

Abstract

Delivering the virus genome into the host nucleus through the nuclear pore complex (NPC) is pivotal in human immunodeficiency virus 1 (HIV-1) infection. The mechanism of this process remains mysterious owing to the NPC complexity and the labyrinth of molecular interactions involved. Here we built a suite of NPC mimics-DNA-origami-corralled nucleoporins with programmable arrangements-to model HIV-1 nuclear entry. Using this system, we determined that multiple cytoplasm-facing Nup358 molecules provide avid binding for capsid docking to the NPC. The nucleoplasm-facing Nup153 preferentially attaches to high-curvature regions of the capsid, positioning it for tip-leading NPC insertion. Differential capsid binding strengths of Nup358 and Nup153 constitute an affinity gradient that drives capsid penetration. Nup62 in the NPC central channel forms a barrier that viruses must overcome during nuclear import. Our study thus provides a wealth of mechanistic insight and a transformative toolset for elucidating how viruses like HIV-1 enter the nucleus.

Indexed as

HIV-1Nuclear Pore Complex ProteinsActive Transport, Cell NucleusCapsid ProteinsCell LineDNAHumansNuclear PoreCapsid ProteinsDNANuclear Pore Complex ProteinsNUP153 protein, human

Identifiers

PMID36807645
PMCPMC10121901
OpenAlexW4321369678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.